Advanced search

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms

Author
Organization
Keywords
Hematology

Citation

Please use this url to cite or link to this publication:

Chicago
Goossens, Steven, Jueqiong Wang, Cedric Tremblay, Jelle De Medts, Sara T’Sas, Thao Nguyen, Jesslyn Saw, et al. 2019. “ZEB2 and LMO2 Drive Immature T-cell Lymphoblastic Leukemia via Distinct Oncogenic Mechanisms.” Haematologica.
APA
Goossens, S., Wang, J., Tremblay, C., De Medts, J., T’Sas, S., Nguyen, T., Saw, J., et al. (2019). ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms. HAEMATOLOGICA.
Vancouver
1.
Goossens S, Wang J, Tremblay C, De Medts J, T’Sas S, Nguyen T, et al. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms. HAEMATOLOGICA. 2019;
MLA
Goossens, Steven et al. “ZEB2 and LMO2 Drive Immature T-cell Lymphoblastic Leukemia via Distinct Oncogenic Mechanisms.” HAEMATOLOGICA (2019): n. pag. Print.
@article{8591823,
  author       = {Goossens, Steven and Wang, Jueqiong and Tremblay, Cedric and De Medts, Jelle and T'Sas, Sara and Nguyen, Thao and Saw, Jesslyn and Haigh, Katharina and Curtis, David J and Van Vlierberghe, Pieter and Berx, Geert and Taghon, Tom and Haigh, Jody J},
  issn         = {0390-6078},
  journal      = {HAEMATOLOGICA},
  language     = {eng},
  title        = {ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms},
  url          = {http://dx.doi.org/10.3324/haematol.2018.207837},
  year         = {2019},
}

Altmetric
View in Altmetric